Concepedia
Statistics
Publications
20
Citations
982
H-Index
17
Active since
2009
Affiliations
Roche (Switzerland)(Current)
Cornell University
La Roche College
Pfizer (United States)
University of Washington
Mohammed Ullah is an author at Roche (Switzerland) specializing in medicine, pharmacology, and cell biology.
Top concepts
MedicineCell BiologyPharmacologyImmunologyProteomicsBioanalysisBiochemistryBiostatisticsImmunotherapyDrug Discovery
Publications per year
2009–2022
Risdiplam distributes and increases <scp>SMN</scp> protein in both the central nervous system and peripheral organs
Agnès Poirier, Marla Weetall, Katja Heinig et al. · Pharmacology Research & Perspectives · 2018 · 160 citations · Full text
Loss of <scp>TMEM</scp> 106B and <scp>PGRN</scp> leads to severe lysosomal abnormalities and neurodegeneration in mice
Tuancheng Feng, Shuyi Mai, Jenn Marie Roscoe et al. · EMBO Reports · 2020 · 107 citations · Full text
Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein
Holger Fischer, Mohammed Ullah, Cecile C. de la Cruz et al. · Neuro-Oncology · 2020 · 100 citations · Full text
Minimizing DILI risk in drug discovery — A screening tool for drug candidates
Simone Schadt, Silke Simon, Stefan Kustermann et al. · Toxicology in Vitro · 2015 · 88 citations
Drug Target, Hit Identification, Drug Candidates +8
Refining the In Vitro and In Vivo Critical Parameters for P-Glycoprotein, [I]/IC<sub>50</sub>and [I<sub>2</sub>]/IC<sub>50</sub>, That Allow for the Exclusion of Drug Candidates from Clinical Digoxin Interaction Studies
Jack Cook, Bo Feng, Katherine S. Fenner et al. · Molecular Pharmaceutics · 2009 · 58 citations
1–5 of 20